Get all the product labeling information by clicking this link Secretropin.

The Millennium Health Centers, Inc is committed to a long term, Prospective Clinical Study on the efficacy and benefits from Secretropin. In lieu of subjective testing used by the majority of other secretagogue products, The Millennium continues to obtain objective results through continued laboratory testing. In so doing, we have found that 8% of the patient population did not respond to the product. In that group of non-responders, we believe that they are Somatostatin sensitive individuals, those that appear to produce naturally high levels of Somatostatin. The addition of supplemental nocturnal L-Arginine, has helped them to respond to Secretropin.

2009: Preservation of Endogenous Growth Hormone Production Using a Combined rhGH-Secretagogue Protocol; The GH-SRx Protocol. Interventional Endocrinology Protocols, Gordon, ML,, Crisler, J., Anand S., Chiapuzio,C. July 17, 2009.

2009: Secretropin - A Nanoliposomal Delivered Secretagogue finishes a second year of clinical evaluation. Journal of Anti Aging Protocology, Vol. 4, No. 1, January 2009. Gordon, ML. Gordon, EF, Gordon, AM. March 17, 2009

2008: A Nanoliposomal - Amino Acid Complex as a Potent Growth Hormone Secretagogue; a Second Look. Journal of Anti Aging Protocology, Vol. 3, No. 3, March 2008. Gordon, Mark L; Gordon, Erin F; Gordon, Alison M; and Gordon, Rochelle H.

Endocrine Disrupting Chemicals An Endocrine Society Scientific Statement June 2009